These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15850970)

  • 21. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
    Moriyama M; Miwa H; Moriya N; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
    Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
    Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combination therapy with a methionine-mitomycin C conjugate and a methionine-deficient diet on tumor growth.
    Yoshida S; Yamana H; Tanaka T; Ishibashi N; Toh U; Ishii H; Shirouzu Y; Shirouzu K
    In Vivo; 1998; 12(3):351-5. PubMed ID: 9706483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
    Zhang SY; Li S; Chen LJ; Shu YH; Zhang XY; Chen XT
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):556-60. PubMed ID: 2130622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
    Xin Y; Lyness G; Chen D; Song S; Wientjes MG; Au JL
    J Urol; 2005 Jul; 174(1):322-7. PubMed ID: 15947683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
    Fujita T; Tamura T; Yamada H; Yamamoto A; Muranishi S
    J Drug Target; 1997; 4(5):289-96. PubMed ID: 9169985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune effects of edible fungus polysaccharides compounds in mice.
    Yin Y; Fu W; Fu M; He G; Traore L
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():258-60. PubMed ID: 17392115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
    Cormary C; Gonzalez R; Faye JC; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.
    Ishiki N; Onishi H; Machida Y
    Int J Pharm; 2004 Jul; 279(1-2):81-93. PubMed ID: 15234797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemical characterization and biological activity of the immunologically active substances in Juzen-taiho-to (Japanese kampo prescription)].
    Yamada H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1500-5. PubMed ID: 2786380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
    Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
    Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
    Qu QL; Zhang YG; Yang LZ; Sun L
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells.
    Ma LW; Moan J; Berg K; Peng Q; Steen HB
    Radiat Res; 1993 Apr; 134(1):22-8. PubMed ID: 8475251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antitumor effect induced by local injections with interleukin-2 is diminished by combing with a local injection with mitomycin C.
    Li T; Harada M; Tamada K; Abe K; Ito O; Takenoyama M; Nomoto K
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):497-509. PubMed ID: 8933166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
    Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.